首页> 外文期刊>RSC Advances >Fabrication and characterization of a folic acid-bound 5-fluorouracil loaded quantum dot system for hepatocellular carcinoma targeted therapy
【24h】

Fabrication and characterization of a folic acid-bound 5-fluorouracil loaded quantum dot system for hepatocellular carcinoma targeted therapy

机译:用于肝细胞癌靶向治疗的叶酸结合5-氟尿嘧啶的叶酸结合5-氟尿嘧啶的制备与表征

获取原文
获取原文并翻译 | 示例
           

摘要

In the present study, we covalently coupled folic acid (FA) and 5-fluorouracil acetic acid (FUA) on the surface of quantum dots (QDs) to produce a tumor targeting drug delivery system, FA-QDs-FUA. The QDs not only act as hepatocellular carcinoma (HCC)-targeted delivery vehicles, but also play a key role in imaging. The structural and optical properties of as-prepared FA-QDs-FUA were characterized using UV-visible spectra, fluorescence spectra, infrared spectra, particle size and zeta potential. In vitro hemolysis activity, cytotoxicity and targeting specificity of the FA-QDs-FUA system were also evaluated. The in vivo anti-tumor efficacy of FA-QDs-FUA in tumor-bearing mice was investigated. The average particle size and zeta potential of FA-QDs-FUA was 220.28 nm and -13.3 mV, respectively. The drug-loading content of FA-QDs-FUA was 36.85% +/- 1.61% (n = 3). The in vitro release profile of 5-FU from FA-QDs-FUA demonstrated a slow and sustained release behaviour as compared to free 5-FU drug. The results of the in vitro cellular experiment demonstrated that FA-QDs-FUA reduced cytotoxicity as compared to free 5-FU and targeted more easily hepatocellular carcinoma cells (SMMC-7721 and HepG2) than normal cells. Mice treated with FA-QDs-FUA showed superior tumor suppression compared to those treated with free 5-FU at 4.72 mg kg(-1) of 5-FU. Therefore, the FA-QDs-FUA system can be used as a promising candidate for improving 5-FU efficacy and tumor targeting specificity with limited toxicity.
机译:在本研究中,我们在量子点(QDS)表面​​上共价偶联叶酸(Fa)和5-氟尿嘧啶乙酸(FUA),以产生靶向药物递送系统,FA-QDS-FUA。 QDS不仅充当肝细胞癌(HCC)的递送车辆,而且在成像中也发挥着关键作用。使用UV可见光谱,荧光光谱,红外光谱,粒度和Zeta电位表征了如制备的FA-QDS-FUA的结构和光学性质。还评估了体外溶血活性,对FA-QDS-FUA系统的细胞毒性和靶向特异性。研究了FA-QDS-FUA在携带肿瘤小鼠中的体内抗肿瘤疗效。 FA-QDS-FUA的平均粒度和ζ电位分别为220.28nm和-13.3mV。 FA-QDS-FUA的药物负载含量为36.85%+/- 1.61%(n = 3)。与Fa-QDS-FUA的5-FU的体外释放曲线显示出与Free 5-Fu药物相比缓慢和持续的释放行为。体外细胞试验的结果表明,FA-的QD-FUA降低的细胞毒性相比,游离的5-FU和有针对性的更容易肝细胞癌细胞(SMMC-7721和HepG2)比正常细胞。用Fa-QDS-FUA处理的小鼠显示出优异的肿瘤抑制,与用5-72mg kg(-1)的5-fu的5-fu治疗。因此,FA-的QD-FUA系统可被用作一个有希望的候选用于提高5-FU的功效和肿瘤具有有限毒性靶向特异性。

著录项

  • 来源
    《RSC Advances》 |2018年第35期|共11页
  • 作者单位

    Univ South China Inst Pharm &

    Pharmacol Hengyang Hunan Peoples R China;

    Univ South China Inst Pharm &

    Pharmacol Hengyang Hunan Peoples R China;

    Hunan Prov Cooperat Innovat Ctr Mol Target New Dr Hengyang Hunan Peoples R China;

    Hunan Prov Cooperat Innovat Ctr Mol Target New Dr Hengyang Hunan Peoples R China;

    Hunan Prov Cooperat Innovat Ctr Mol Target New Dr Hengyang Hunan Peoples R China;

    Hunan Prov Cooperat Innovat Ctr Mol Target New Dr Hengyang Hunan Peoples R China;

    Univ South China Inst Pharm &

    Pharmacol Hengyang Hunan Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号